DPP-4
Los inhibidores de DPP-4 son compuestos que inhiben la Dipeptidil Peptidasa-4, una enzima implicada en la inactivación de las hormonas incretinas, que regulan el metabolismo de la glucosa. Al inhibir DPP-4, estos compuestos ayudan a prolongar la acción de las hormonas incretinas, mejorando la secreción de insulina y reduciendo los niveles de glucosa en sangre. Los inhibidores de DPP-4 se utilizan ampliamente en el tratamiento de la diabetes tipo 2 y en investigaciones centradas en trastornos metabólicos. En CymitQuimica, ofrecemos inhibidores de DPP-4 para apoyar su investigación en endocrinología, manejo de la diabetes y enfermedades metabólicas.
Se han encontrado 90 productos para "DPP-4".
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Trelagliptin
CAS:Trelagliptin (SYR-472) is a highly specific and long-acting DPP-4 inhibitor.Fórmula:C18H20FN5O2Pureza:98.88%Forma y color:SolidPeso molecular:357.38Denagliptin
CAS:Denagliptin is a small molecule dipeptidyl peptidase IV (DPP-4) inhibitor for the treatment of endocrine Ü metabolic diseases and can be used in the study ofFórmula:C20H18F3N3OPureza:99.12%Forma y color:SolidPeso molecular:373.37Begelomab
CAS:Begelomab (SAND-26) is a mouse-derived monoclonal antibody targeting DPP-4/CD26. Begelomab can be used to study severe refractory inflammatory myopathies.Pureza:97.8% (SDS-PAGE); 98.3% (SEC-HPLC) - 97.8% (SDS-PAGE); 98.3% (SEC-HPLC)Forma y color:Transparent LiquidPeso molecular:146.20 kDaDBPR108
CAS:DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9.Fórmula:C16H25FN4O2Pureza:99.68%Forma y color:SolidPeso molecular:324.39Ref: TM-T15079
1mg48,00€5mg100,00€1mL*10mM (DMSO)110,00€10mg133,00€25mg215,00€50mg306,00€100mg414,00€200mg573,00€Saxagliptin hydrate
CAS:Saxagliptin hydrate (Onglyza hydrate) is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).Fórmula:C18H25N3O2·H2OPureza:99.52%Forma y color:SolidPeso molecular:333.43Retagliptin Phosphate
CAS:Retagliptin Phosphate (SP 2086) is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.Fórmula:C19H21F6N4O7PPureza:98.70%Forma y color:SolidPeso molecular:562.36Ref: TM-T12710
100mgA consultar1mg34,00€2mg42,00€5mg60,00€1mL*10mM (DMSO)79,00€10mg87,00€25mg161,00€50mg245,00€SGLT2-IN-6
SGLT2-IN-6 (Compound 101) is an orally active SGLT2 inhibitor with IC₅₀ values of 0.8 nM, 6.7 nM, and 72 nM for SGLT2, SGLT1, and DPP4, respectively. In diabetic rat models, SGLT2-IN-6 controls blood glucose levels and increases active GLP-1 levels. It is suitable for research on type 2 diabetes.Camegliptin
CAS:Cameglipti, a dipeptidyl peptidase IV (DPP-4) inhibitor, is used potentially for the treatment of type 2 diabetes.Fórmula:C20H28FN3O3Forma y color:SolidPeso molecular:377.45Linagliptin Methyldimer
CAS:Linagliptin Methyldimer is a potent dipeptidyl peptidase IV inhibitor, IC50=6 pM.Fórmula:C50H56N16O4Pureza:99.91%Forma y color:SolidPeso molecular:945.08Ellipyrone A
Ellipyrone A: γ-pyrone macrocycle, inhibits DPP-4 (IC50=0.35mM), α-glucosidase (IC50=0.74mM), α-amylase (IC50=0.59mM).Fórmula:C25H34O8Forma y color:SolidPeso molecular:462.53SGLT2-IN-5
SGLT2-IN-5 (Compound 99) is an orally active SGLT2 inhibitor with IC₅₀ values of 0.8 nM for SGLT2, 23 nM for SGLT1, and 58 nM for DPP4. In diabetic rat models, SGLT2-IN-5 effectively regulates blood glucose and increases the levels of active GLP-1. It is suitable for research on type 2 diabetes.Fotagliptin
CAS:Fotagliptin is a dipeptidyl peptidase IV inhibitor.Fórmula:C17H19FN6OForma y color:SolidPeso molecular:342.37Dutogliptin tartrate
CAS:Dutogliptin tartrate is an effective and selective oral dipeptide-peptide-4 (DPP4) inhibitor for the treatment of type 2 diabetes mellitus.Fórmula:C14H26BN3O9Pureza:98%Forma y color:SolidPeso molecular:391.18HAEGT
CAS:HAEGT is the first N-terminal 1-5 residues of GLP-1 peptide.Fórmula:C20H31N7O9Pureza:98%Forma y color:SolidPeso molecular:513.5DPP-4/GPR119 modulator 1
CAS:Orally active DPP-4 inhibitor/GPR119 agonist, Compound 22 lowers glucose, moderate hERG inhibition, IC50 4.9 µM, for diabetes research.Fórmula:C30H39ClN10O3Forma y color:SolidPeso molecular:623.15AMG-222
CAS:AMG-222 (ALS-2-0426, ALS-20426) is a DPP-4 inhibitor and may be used in the treatment of type 2 diabetes.Fórmula:C32H39N9O3Forma y color:SolidPeso molecular:597.71Talabostat isomer mesylate
Talabostat isomer mesylate, a PT100/Val-boroPro variant, is a potent oral DPP-IV inhibitor (Ki: 0.18 nM).Fórmula:C10H23BN2O6SPureza:98%Forma y color:SolidPeso molecular:310.18(-)-Sitagliptin Carbamoyl Glucuronide
CAS:Minor phase II metabolite of DPP-4 inhibitor sitagliptin, found in rat and dog plasma.Fórmula:C23H23F6N5O9Forma y color:SolidPeso molecular:627.453Sitagliptin fenilalanil hydrochloride
CAS:Sitagliptin fenilalanil hydrochloride is an orally active DPP-4 inhibitor. Sitagliptin fenilalanil hydrochloride is used in diabetes research.Fórmula:C25H25ClF6N6O2Pureza:98.32%Forma y color:White SolidPeso molecular:590.95Fotagliptin benzoate
CAS:Fotagliptin benzoate, a DPP-4 inhibitor (IC50=2.27 nM), is safe in rats/dogs, useful for Type 2 diabetes research.Fórmula:C24H25FN6O3Forma y color:SolidPeso molecular:464.49
